Related Experiment Video
Updated: Feb 9, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Melanoma Immunotherapy: Next-Generation Biomarkers
Sabrina A Hogan1,2, Mitchell P Levesque1,2, Phil F Cheng1,2
1Department of Dermatology, UniversitätsSpital Zürich, Gloriastrasse, Zurich, Switzerland.
Abstract:
The recent emergence of cancer immunotherapies initiated a significant shift in the clinical management of metastatic melanoma. Prior to 2011, melanoma patients only had palliative treatment solutions which offered little to no survival benefit. In 2018, with immunotherapy, melanoma patients can now contemplate durable or even complete remission. Treatment with novel immune checkpoint inhibitors, anti-cytotoxic T-lymphocyte protein 4 and anti-programmed cell death protein 1, clearly result in superior median and long-term survivals compared to standard chemotherapy; however, more than half of the patients do not respond to immune checkpoint blockade. Currently, clinicians do not have any effective way to stratify melanoma patients for immunotherapies. Research is now focusing on identifying biomarkers which could predict a patient's response prior treatment initiation (or very early during treatment course), in order to maximize therapeutic efficacy, avoid unnecessary costs, and undesirable heavy side effects for the patient. Given the rapid developments in this field and the translational potential for some of the biomarkers, we will summarize the current state of biomarker research for immunotherapy in melanoma, with an emphasis on omics technologies such as next-generation sequencing and mass cytometry (CyTOF).
Insights
Cancer immunotherapies offer improved survival for melanoma patients. Biomarker research, using omics technologies, aims to predict treatment response and personalize therapy for better outcomes.
Area of Science:
- Oncology
- Immunology
- Biomarker Discovery
Background:
- Metastatic melanoma treatment has been revolutionized by cancer immunotherapies, offering durable remission unlike prior palliative options.
- Immune checkpoint inhibitors (anti-CTLA-4, anti-PD-1) show superior survival but over 50% of patients do not respond.
- Effective patient stratification for immunotherapy remains a clinical challenge.
Purpose of the Study:
- To review current biomarker research for predicting immunotherapy response in melanoma.
- To highlight the role of omics technologies in identifying predictive biomarkers.
- To guide personalized treatment strategies and improve patient outcomes.
Main Methods:
- Review of current literature on melanoma immunotherapy biomarkers.
- Emphasis on omics technologies: next-generation sequencing and mass cytometry (CyTOF).
- Analysis of biomarker potential for patient stratification.
Main Results:
- Immune checkpoint inhibitors significantly improve survival compared to chemotherapy.
- A substantial proportion of patients lack response to current immunotherapies.
- No established methods currently exist to effectively stratify melanoma patients for immunotherapy response.
Conclusions:
- Biomarker identification is crucial for optimizing melanoma immunotherapy efficacy.
- Omics technologies hold significant promise for discovering predictive biomarkers.
- Personalized treatment approaches based on biomarkers can minimize costs and side effects.
Related Concept Videos
Tumor Immunotherapy
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
DC Generator
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Generation Time
Electric Generator: Alternator
The magnetic flux passing through the coil varies sinusoidally as the loop rotates inside the magnetic field. This...

